Biomarkers in cancer staging, prognosis and treatment selection

被引：1245

作者：

Ludwig, JA

Weinstein, JN ^{[1
]}

机构：

[1] NCI, Genom & Bioinformat Grp, Mol Pharmacol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA

[2] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

NATURE REVIEWS CANCER | 2005年 / 5卷 / 11期

关键词：

D O I：

10.1038/nrc1739

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Advances in genomics, proteomics and molecular pathology have generated many candidate biomarkers with potential clinical value. Their use for cancer staging and personalization of therapy at the time of diagnosis could improve patient care. However, translation from bench to bedside outside of the research setting has proved more difficult than might have been expected. Understanding how and when biomarkers can be integrated into clinical care is crucial if we want to translate the promise into reality.

引用

页码：845 / 856

页数：12

共 148 条

[11] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
Belinsky, SA
Nikula, KJ
Palmisano, WA
Michels, R
Saccomanno, G
Gabrielson, E
Baylin, SB
Herman, JG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11891 - 11896
[12] Nanoscale quantum dots hold promise for cancer applications
Ben-Ari, ET
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (07) : 502 - 504
[13] Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis
Best, CJM
Leiva, IM
Chuaqui, RF
Gillespie, JW
Duray, PH
Murgai, M
Zhao, YD
Simon, R
Kang, JJ
Green, JE
Bostwick, DG
Linehan, WM
Emmert-Buck, MR
[J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2003, 12 (02) : 63 - 70
[14] Mitochondrial genome instability in human cancers
Bianchi, NO
Bianchi, MS
Richard, SM
[J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2001, 488 (01) : 9 - 23
[15] Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M
Meitzer, P
Chen, Y
Jiang, Y
Seftor, E
Hendrix, M
Radmacher, M
Simon, R
Yakhini, Z
Ben-Dor, A
Sampas, N
Dougherty, E
Wang, E
Marincola, F
Gooden, C
Lueders, J
Glatfelter, A
Pollock, P
Carpten, J
Gillanders, E
Leja, D
Dietrich, K
Beaudry, C
Berens, M
Alberts, D
Sondak, V
Hayward, N
Trent, J
[J]. NATURE, 2000, 406 (6795) : 536 - 540
[16] In vivo detection and imaging of phosphatidylserine expression during programmed cell death
Blankenberg, FG
Katsikis, PD
Tait, JF
Davis, RE
Naumovski, L
Ohtsuki, K
Kopiwoda, S
Abrams, MJ
Darkes, M
Robbins, RC
Maecker, HT
Strauss, HW
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6349 - 6354
[17] Haplotype and linkage disequilibrium architecture for human cancer-associated genes
Bonnen, PE
Wang, PJ
Kimmel, M
Chakraborty, R
Nelson, DL
[J]. GENOME RESEARCH, 2002, 12 (12) : 1846 - 1853
[18] KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS INFECTS ENDOTHELIAL AND SPINDLE CELLS
BOSHOFF, C
SCHULZ, TF
KENNEDY, MM
GRAHAM, AK
FISHER, C
THOMAS, A
MCGEE, JO
WEISS, RA
OLEARY, JJ
[J]. NATURE MEDICINE, 1995, 1 (12) : 1274 - 1278
[19] MOLECULAR ASSESSMENT OF HISTOPATHOLOGICAL STAGING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
BRENNAN, JA
MAO, L
HRUBAN, RH
BOYLE, JO
EBY, YJ
KOCH, WM
GOODMAN, SN
SIDRANSKY, D
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (07) : 429 - 435
[20] Britz-Cunningham SH, 2003, J NUCL MED, V44, P1945

← 1 2 3 4 5 6 7 8 9 10 →